December 2021

Saphnelo From AstraZeneca

December 31, 2021

The FDA approves anifrolumab-fnia injection (Saphnelo; AstraZeneca) for the treatment of adults with moderate to severe system- ic lupus erythematosus (SLE) who are receiving standard therapy.

Link Is Seen to Commonly Screened Protein During Pregnancy

December 22, 2021

Disease State Management

The data highlight a new role for pregnancy-associated plasma protein A, known as PAPP-A, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target, according to the investigators.

Research Shows Increased Risk of Heart Disease for Women

December 17, 2021

Disease State Management

The new analysis includes approximately 1100 women without type 1 or type 2 diabetes (T2D) who subsequently gave birth at least once during the 25-year study period, which ended in 2011.

Study Suggests Eating Habits Barely Change After Diabetes Diagnosis

December 13, 2021

The investigators analyzed an existing data set from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies, which included surveys on diet and exercise from a diverse patient population at 12 hospital centers across the United States.